SlideShare a Scribd company logo
1Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Absolute quantification of
mAbs and ADCs: forget
amino acid analysis and
shift to the new gold
standard
Arnaud Delobel, PhD
Director, R&D
2Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Agenda
• Presentation of Quality Assistance
• Absolute quantification: why and how?
• Development of an ICP/MS method for protein quantification
• Method validation
• How to apply the method to ADCs?
3Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Quality Assistance sa
100% analytical services
100% (bio)pharmaceutical industry
189 highly-qualified employees
> 60% university graduates
77 worldwide R&D companies
& 200 projects (2018)
Product dedicated support
Customised project management
Compliance with EMA / FDA regulations
From discovery to market place
All laboratories on one site
5700 m²
9600 hours
5 clients
8 projects
ADC expertise
(2018)
+35 years experience
~1.1 M € in machinery
& equipment (2018)
22200 hours
16 clients
35 projects
mAbs expertise
(2018)
4Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Quantity of the active substance in a drug product is a critical
quality attribute, directly linked to the efficacy and safety of the drug
• A precise and accurate method is required to evaluate batch-to-
batch consistency
• Determination of protein concentration is a prerequisite to measure
the extinction coefficient ε of a protein
▪ ε is used as part of the fine characterisation of a protein
▪ ε is used for comparability or biosimilarity studies
Quantification of proteins: why?
5Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Absolute vs relative quantification: What does absolute mean ?
▪ Quantification without the reference substance
▪ No need for a well characterised standard of the protein to be quantified!
• Usual « absolute » methods
▪ Colorimetric (Lowry, Bradford, BCA, …)
• Usually with BSA as standard: large variability, important bias (up to 50 %)
▪ Amino Acid Analysis
▪ UV spectroscopy: requires knowledge of the molar extinction coefficient, in other
words prior availability of the reference protein
• Classical relative methods
▪ ELISA, LC-MS, LC-UV, …
▪ All require calibration with a standard solution of the protein to be assayed. Such a
standard is not readily available in most cases
Quantification of proteins: how?
6Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Complex workflow:
• Low throughput method
• High variability (%RSD: 5 – 10 %)
• Low accuracy (90 – 110 %)
Amino Acid Analysis
Vacuum acidic
hydrolysis
Derivatisation
UPLC/UV
analysis
7Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Inductively-Coupled Plasma / Mass Spectrometry
ICP/MS
8Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Metallo-proteins
▪ ICP-MS obvious for a protein containing a metallic hetero-element with a
known stoechiometry.
• Fe for Hemoglobin
• Se for a Seleno-protein
▪ But applicable for a few proteins only !
• Common proteins
▪ Most proteins (> 95 %) contain Sulphur (Methionine and Cysteine residues)
▪ If elemental composition known:
Sulphur determination = protein quantification
▪ e.g. BSA : C2932H4614N780O898S39 : 1.883 % (w/w) S
Why ICP/MS for protein analysis?
9Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• High ionization potential (10.4 eV) → low sensitivity
• For 32S+, 34S+, 32SO+, 34SO+ : many polyatomic interferences
Sulphur determination by ICP/MS: a challenge!
10Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Sulphur determination by ICP/MS
• New instrument technology available: ICP-QQQ
(Agilent 8800/8900 Triple Quadrupole)
• Allows operation in MRM-like mode
• Elimination of virtually all interferences
• High sensitivity
• LOQ governed by residual sulphur in reagents and solvents
11Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Sample preparation: digestion is needed
• High sensitivity requires low contamination
• Sulphur contained in the formulation must be taken into account
• To increase accuracy and precision: isotope dilution with 34SO4
(IDMS)
Method development
Undigested sample solutions Sulphur recovery
1 ppm S as H2SO4 100 %
1 ppm S as Methionine > 95 %
1 ppm S as BSA < 90 %
12Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Quantification using Isotope Dilution
13Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Quantification using Isotope Dilution
14Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Quantification using Isotope Dilution
15Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Isotope ratio: Q1 & Q2 are set alternatively to 32/48 or 34/50 to measure 32S or
34S
• Double IDMS
▪ Black marbles = 34SO4 solution added to samples
▪ 34SO4 spiking solution is prepared by oxidation of 34S Sulfur: its exact concentration is not
accurately known.
▪ Concentration of the 34SO4 solution is determined by reverse IDMS with a certified solution of
SO4 (natural Sulfur isotopic abundance), NIST traceable.
▪ Reverse isotope dilution allows also to compensate for sentivity differences observed in
ICP-MS between 32S and 34S (mass discrimination)
Quantification using Isotope Dilution
16Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Workflow of the method
34S
Oxidation
(HNO3 / H2O2, 30’)
Standard stock
solution
Addition of sulphur
ICP standard
17Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Workflow of the method
34S
Mineralisation
(HNO3 / H2O2, 30’)
Standard stock
solution
Addition of sulphur
ICP standard
18Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Workflow of the method
Standard stock
solution
Sample solution
(50 µg S in 1-5 mL)
3 kDa MWCO-filtered
sample solution
Mineralisation
(HNO3 / H2O2 / HCl, 30’)
ICP-MS/MS analysis
Sulphur (32S/34S) quantification by IDMS
Absolute protein
quantification
19Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
ICP-MS parameters
• RF power: 1550 W
• Ar carrier gas: 0.25 L/min
• Dilution gas (Ar): 0.85 L/min
• O2 in reaction cell: 0.35 ml/min
• First quadrupole at m/z = 32 (or 34 for 34S)
• Last quadrupole at m/z = 48 (or 50 for 34SO+)
Total: 1.1 L/min
20Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• According to ICH Q2(R1) guideline
(Validation of analytical procedures – Text and methodology)
• Model compound: BSA (Bovine Serum Albumin)
NIST certified solution: 67.38  1.38 g/L ( 2.0 %)
• Additional compounds tested
▪ Trastuzumab solution (label concentration: 21 mg/mL)
▪ Human IgG (Immunoglobulins mixture from Ph. Eur.)
▪ USP BSA for Protein Quantitation RS (2.00 mg/mL)
Method validation
21Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Linearity of the method:
▪ R = 0.99998
▪ Precision: RSD < 0.4 %
▪ Accuracy: 101.2 – 101.3 %
Method validation - Linearity
BSA (SRM 927e)
(mg)
Sulphur
(µg)
Sulphur
(µg/g)
Average
recovery (%)
RSD
(%)
n
1.6 30 0.6 101.29 0.34 3
2.1 40 0.8 101.30 0.21 3
2.6 50 1.0 101.26 0.22 6
3.2 60 1.2 101.17 0.13 3
3.7 70 1.4 101.17 0.12 3
y = 19.02520x + 0.09521
R² = 0.99996
20
30
40
50
60
70
80
1 1.5 2 2.5 3 3.5 4
Sulfurfound,µg
Sample mass (BSA dose, mg)
22Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Method validation - Precision
(repeatability and intermediate precision)
• Two different analysts carried out independently 6 determinations of
the same solution of BSA and human IgG .
• Samples
▪ BSA: NIST, SRM 927e: 67.38 mg/mL
▪ IgG: human immunoglobulin BRP batch 1
• Ph. Eur. Reference standard for molecular size: unknown content
Sample Analyst 1 Analyst 2 Total RSD (%)
Average % RSD (n = 6) Average % RSD (n = 6) n = 12
NIST BSA (mg/mL) 67.28 0.41 67.50 0.52 0.6
IgG (mg S/g) 8.39 0.13 8.33 0.19 0.7
23Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Evaluation of matrix effect
▪ Same amount of BSA spiked with different formulation ingredients
Method validation – Matrix effect
Matrix Mean recovery (%) % RSD (n = 3)
0.9 % NaCl 100.27 0.05
PBS 100.24 0.36
10 % Sucrose 100.16 0.61
0.1 % PS-80 100.26 0.57
15 mg/mL Glycine 99.61 0.37
15 mg/mL Histidine 100.76 0.23
Worst case 100.33 0.21
24Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Quantification in the presence of non-proteinaceous sulphur:
▪ Source of non-protein sulphur: Sulphate
▪ A BSA solution is spiked with SO4 ( 5 % of BSA Sulphur)
▪ Part of this solution is filtered through 3 kDa
• Corrected BSA recovery in spiked solution: 99.6 %
Method validation – Matrix effect
Sample Sulphur (µg/g)
A: unspiked BSA solution 36.50
B: spiked BSA solution 38.81
C: filtered solution 2.44
B-C 36.37
25Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Method validation – Matrix effect
• Quantification in the presence of non-proteinaceous sulphur:
▪ Non-protein sulphur: Methionine
▪ Methionine was added to BSA and IgG solution
▪ Solutions were filtered and Methionine recovery measured in filtrate
25
BSA sol IgG sol
Methionine added (mM) 2.05 2.05
Methionine in filtrate (mM) 2.03 2.04
% recovery 99.1 99.5
26Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Method validation - Stability of solutions
• Stability of standard, sample and blank solutions were studied after
digestion and dilution
• Storage in metal-free polypropylene tubes
• 34S/32S ratios measured on different days:
no change > 1 % in 7 days
→ All solutions are stable for at least 7 days
27Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Method validation – Impact of sample dilution
• What if we have a sample with low protein concentration?
→ Need for a large volume of sample to get 50 µg of S
→ Dilution of acids used for digestion
→ Will the digestion be complete?
• Test:
▪ Constant amount of BSA solution (40 mg) and of 34SO4
▪ Constant volumes of digestion reagents
(2 mL HNO3, 0.5 mL HCl, 1 mL H2O2)
▪ Variable volumes of water added before digestion (1 to 5 mL)
28Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Method validation – Impact of sample dilution
BSA solution
(mg)
H2O
(mL)
Mean recovery
(%)
RSD
(%)
n
40 0.9 100.51 0.32 3
40 1.4 100.92 0.34 3
40 2.0 100.59 0.18 3
40 2.5 100.64 0.07 3
40 3 100.32 0.14 3
40 4 100.89 0.15 3
40 5 100.77 0.18 3
29Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Study on Trastuzumab and USP BSA
Trastuzumab solution
• Expected concentration: 21 mg/mL
• Unknown formulation
• Non proteinaceous Sulphur: 1.7 ppb ( 0.2 % of Trastuzumab Sulphur)
• Found: 20.53 mg/g (RSD = 0.02 %, n = 3)
• Recovery: 97.8 % (vs. the nominal concentration)
• Result should be corrected for density (unknown)
BSA for Protein Quantitation (USP Reference Standard)
• Label concentration: 2.00 mg/mL (unknown accuracy, determined on basis of UV
280nm absorption)
• Found: 1.96 mg/mL (RSD = 0.4 %, n=3)
• Recovery: 98.0 % (vs. label concentration)
30Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Conclusions
• The method characteristics are:
▪ Good sensitivity: 1 or 2 mg of protein in 5 mL is enough
▪ High reproducibility: RSD < 1 %
▪ Great accuracy: < 2 % bias
▪ Insensitivity to matrix effect
▪ Same method for any protein or peptide
▪ Uses only very common reagents and standards
▪ Fast: results obtained within half a day of lab work in routine use
• It is suitable for:
▪ Assay of a single protein or mAb in solution
▪ Assay of a protein adsorbed on an adjuvant (vaccines)
▪ Accurate determination of a protein or peptide standard solution concentration
▪ Determination of the molar extinction coefficient
• Excellent orthogonal method to colorimetry, AAA, theoretical molar extinction
coefficient
31Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Comparison of protein quantification methods not requiring
the reference protein
Colorimetry
Extinct. coeff.
(calculated)
Amino Acids
Analysis
Sulfur by
ICP-MS
Single protein Yes Yes Yes Yes
Need for a standard
protein
Yes (BSA) No
No
(Amino Acids)
No
(Sulfate sol.)
Bias Significant
Can be
significant
5 - 10 % < 2 %
Precision (% RSD) > 5 % N/A > 5 % < 1 %
Interferences Yes
Yes
(ex: ADC)
No No
32Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
How to apply the method to ADCs?
• If the drug/linker contains no sulphur: easy!
• If the drug/linker contains sulphur:
Determination
of DAR by LC/MS Calculation of mean number
of sulphur atoms per ADC
ICP-MS/MS analysis and
determination of ADC
concentration
33Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Take-Home Messages
AAA is no longer the
reference method for
absolute quantification of
proteins
You no longer have to
accept > 10%
uncertainty in your
extinction coefficient
determination
Our ICP/MS method was
validated and showed
excellent precision and
accuracy
(RSD < 1%, bias < 2%)
The method can be
applied on a wide range
of formulations without
further optimisation The method can be run
in a full GMP
environment
34Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Acknowledgements
• Juliusz Bianga
• Damien Mouvet
• Philippe De Raeve
35Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
arnaud.delobel@quality-assistance.be
+32 71 53 47 81
www.quality-assistance.com
Technoparc de Thudinie, 2
B-6536 Donstiennes (Belgium)
Thank you for
your attention
Any question?

More Related Content

What's hot

Quality and elemental characterization of common spices of Bangladesh using n...
Quality and elemental characterization of common spices of Bangladesh using n...Quality and elemental characterization of common spices of Bangladesh using n...
Quality and elemental characterization of common spices of Bangladesh using n...
Mahfuzur Rahman Titu
 
Sucrose low in nanoparticulate impurities for biopharmaceutical formulations
Sucrose low in nanoparticulate impurities for biopharmaceutical formulationsSucrose low in nanoparticulate impurities for biopharmaceutical formulations
Sucrose low in nanoparticulate impurities for biopharmaceutical formulations
MilliporeSigma
 
2nd Webinar on Nanotechnology and Nanoscience
2nd Webinar on Nanotechnology and Nanoscience2nd Webinar on Nanotechnology and Nanoscience
2nd Webinar on Nanotechnology and Nanoscience
Siti Husnaa Mohd Taib
 
Voltametric determination of acephate pesticide by liquid state lipase enzyma...
Voltametric determination of acephate pesticide by liquid state lipase enzyma...Voltametric determination of acephate pesticide by liquid state lipase enzyma...
Voltametric determination of acephate pesticide by liquid state lipase enzyma...ijsidonlineinfo
 
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Waters Corporation
 
One Pot Hydrothermal Synthesis Characterizations Of Silver Nanoparticles On R...
One Pot Hydrothermal Synthesis Characterizations Of Silver Nanoparticles On R...One Pot Hydrothermal Synthesis Characterizations Of Silver Nanoparticles On R...
One Pot Hydrothermal Synthesis Characterizations Of Silver Nanoparticles On R...
IOSRJAC
 
IFPAC 2013 Baltimore
IFPAC 2013 BaltimoreIFPAC 2013 Baltimore
IFPAC 2013 Baltimoredominev
 

What's hot (7)

Quality and elemental characterization of common spices of Bangladesh using n...
Quality and elemental characterization of common spices of Bangladesh using n...Quality and elemental characterization of common spices of Bangladesh using n...
Quality and elemental characterization of common spices of Bangladesh using n...
 
Sucrose low in nanoparticulate impurities for biopharmaceutical formulations
Sucrose low in nanoparticulate impurities for biopharmaceutical formulationsSucrose low in nanoparticulate impurities for biopharmaceutical formulations
Sucrose low in nanoparticulate impurities for biopharmaceutical formulations
 
2nd Webinar on Nanotechnology and Nanoscience
2nd Webinar on Nanotechnology and Nanoscience2nd Webinar on Nanotechnology and Nanoscience
2nd Webinar on Nanotechnology and Nanoscience
 
Voltametric determination of acephate pesticide by liquid state lipase enzyma...
Voltametric determination of acephate pesticide by liquid state lipase enzyma...Voltametric determination of acephate pesticide by liquid state lipase enzyma...
Voltametric determination of acephate pesticide by liquid state lipase enzyma...
 
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
 
One Pot Hydrothermal Synthesis Characterizations Of Silver Nanoparticles On R...
One Pot Hydrothermal Synthesis Characterizations Of Silver Nanoparticles On R...One Pot Hydrothermal Synthesis Characterizations Of Silver Nanoparticles On R...
One Pot Hydrothermal Synthesis Characterizations Of Silver Nanoparticles On R...
 
IFPAC 2013 Baltimore
IFPAC 2013 BaltimoreIFPAC 2013 Baltimore
IFPAC 2013 Baltimore
 

Similar to WEBINAR: Absolute quantification of mAbs and ADCs: forget amino acid analysis and shift to the new gold standard

Absolute quantification of mAbs and ADCs : forget amino acid analysis and shi...
Absolute quantification of mAbs and ADCs : forget amino acid analysis and shi...Absolute quantification of mAbs and ADCs : forget amino acid analysis and shi...
Absolute quantification of mAbs and ADCs : forget amino acid analysis and shi...
Quality Assistance s.a.
 
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...
PerkinElmer, Inc.
 
Diclofenac rabeprazole hplc
Diclofenac rabeprazole hplcDiclofenac rabeprazole hplc
Diclofenac rabeprazole hplcDeepak Gadade
 
Art%3 a10.1007%2fs00769 010-0677-6(1)
Art%3 a10.1007%2fs00769 010-0677-6(1)Art%3 a10.1007%2fs00769 010-0677-6(1)
Art%3 a10.1007%2fs00769 010-0677-6(1)
Haruka Tsuyoi
 
Practical Implementation of the New Elemental Impurities Guidelines May 2015
Practical Implementation of the New Elemental Impurities Guidelines May 2015Practical Implementation of the New Elemental Impurities Guidelines May 2015
Practical Implementation of the New Elemental Impurities Guidelines May 2015
SGS
 
Webinar - Get Your Lab Ready for HABs with YSI
Webinar - Get Your Lab Ready for HABs with YSIWebinar - Get Your Lab Ready for HABs with YSI
Webinar - Get Your Lab Ready for HABs with YSI
Xylem - Emerging Markets
 
Novel Approaches to Omega-3 Stability Testing
Novel Approaches to Omega-3 Stability Testing Novel Approaches to Omega-3 Stability Testing
Novel Approaches to Omega-3 Stability Testing
Nutrasource
 
Protein Analysis Methods.pptx
Protein Analysis Methods.pptxProtein Analysis Methods.pptx
Protein Analysis Methods.pptx
ThierryUzabakiriho
 
Food contaminants dhaka university_august2014
Food contaminants dhaka university_august2014Food contaminants dhaka university_august2014
Food contaminants dhaka university_august2014
anisbdinfo
 
Analytical toxicology
Analytical toxicologyAnalytical toxicology
Analytical toxicology
Pankaj Sonsurkar
 
General techniques for identification and characterization of protein and Nuc...
General techniques for identification and characterization of protein and Nuc...General techniques for identification and characterization of protein and Nuc...
General techniques for identification and characterization of protein and Nuc...
JohamSarfrazAli1
 
Chromatography: Trends and Developments in MAb Screening and Characterization
Chromatography: Trends and Developments in MAb Screening and CharacterizationChromatography: Trends and Developments in MAb Screening and Characterization
Chromatography: Trends and Developments in MAb Screening and Characterization
Chromatography & Mass Spectrometry Solutions
 
BR-70346-Research-Production-Biofuel-BR70346-EN
BR-70346-Research-Production-Biofuel-BR70346-ENBR-70346-Research-Production-Biofuel-BR70346-EN
BR-70346-Research-Production-Biofuel-BR70346-ENdmend129
 
Determination of Heavy Metals in Baby Foods by ICP-MS
Determination of Heavy Metals in Baby Foods by ICP-MSDetermination of Heavy Metals in Baby Foods by ICP-MS
Determination of Heavy Metals in Baby Foods by ICP-MS
Shimadzu Scientific Instruments
 
LC-MS/MS analysis of emerging food contaminants
LC-MS/MS analysis of emerging food contaminantsLC-MS/MS analysis of emerging food contaminants
LC-MS/MS analysis of emerging food contaminants
SCIEX
 
Enzyme Based Analytical Chemistry - Nitrate and the U.S. EPA
Enzyme Based Analytical Chemistry - Nitrate and the U.S. EPAEnzyme Based Analytical Chemistry - Nitrate and the U.S. EPA
Enzyme Based Analytical Chemistry - Nitrate and the U.S. EPA
Anna-Marie Davidson
 
PPT on spoilage (1).pptx
PPT on spoilage (1).pptxPPT on spoilage (1).pptx
PPT on spoilage (1).pptx
ChitrarpitaDas2
 
A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...
A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...
A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...
Alok Singh
 

Similar to WEBINAR: Absolute quantification of mAbs and ADCs: forget amino acid analysis and shift to the new gold standard (20)

Absolute quantification of mAbs and ADCs : forget amino acid analysis and shi...
Absolute quantification of mAbs and ADCs : forget amino acid analysis and shi...Absolute quantification of mAbs and ADCs : forget amino acid analysis and shi...
Absolute quantification of mAbs and ADCs : forget amino acid analysis and shi...
 
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...
 
Diclofenac rabeprazole hplc
Diclofenac rabeprazole hplcDiclofenac rabeprazole hplc
Diclofenac rabeprazole hplc
 
Art%3 a10.1007%2fs00769 010-0677-6(1)
Art%3 a10.1007%2fs00769 010-0677-6(1)Art%3 a10.1007%2fs00769 010-0677-6(1)
Art%3 a10.1007%2fs00769 010-0677-6(1)
 
Practical Implementation of the New Elemental Impurities Guidelines May 2015
Practical Implementation of the New Elemental Impurities Guidelines May 2015Practical Implementation of the New Elemental Impurities Guidelines May 2015
Practical Implementation of the New Elemental Impurities Guidelines May 2015
 
Webinar - Get Your Lab Ready for HABs with YSI
Webinar - Get Your Lab Ready for HABs with YSIWebinar - Get Your Lab Ready for HABs with YSI
Webinar - Get Your Lab Ready for HABs with YSI
 
Novel Approaches to Omega-3 Stability Testing
Novel Approaches to Omega-3 Stability Testing Novel Approaches to Omega-3 Stability Testing
Novel Approaches to Omega-3 Stability Testing
 
Protein Analysis Methods.pptx
Protein Analysis Methods.pptxProtein Analysis Methods.pptx
Protein Analysis Methods.pptx
 
Food contaminants dhaka university_august2014
Food contaminants dhaka university_august2014Food contaminants dhaka university_august2014
Food contaminants dhaka university_august2014
 
Analytical toxicology
Analytical toxicologyAnalytical toxicology
Analytical toxicology
 
General techniques for identification and characterization of protein and Nuc...
General techniques for identification and characterization of protein and Nuc...General techniques for identification and characterization of protein and Nuc...
General techniques for identification and characterization of protein and Nuc...
 
Chromatography: Trends and Developments in MAb Screening and Characterization
Chromatography: Trends and Developments in MAb Screening and CharacterizationChromatography: Trends and Developments in MAb Screening and Characterization
Chromatography: Trends and Developments in MAb Screening and Characterization
 
BR-70346-Research-Production-Biofuel-BR70346-EN
BR-70346-Research-Production-Biofuel-BR70346-ENBR-70346-Research-Production-Biofuel-BR70346-EN
BR-70346-Research-Production-Biofuel-BR70346-EN
 
Determination of Heavy Metals in Baby Foods by ICP-MS
Determination of Heavy Metals in Baby Foods by ICP-MSDetermination of Heavy Metals in Baby Foods by ICP-MS
Determination of Heavy Metals in Baby Foods by ICP-MS
 
LC-MS/MS analysis of emerging food contaminants
LC-MS/MS analysis of emerging food contaminantsLC-MS/MS analysis of emerging food contaminants
LC-MS/MS analysis of emerging food contaminants
 
Enzyme Based Analytical Chemistry - Nitrate and the U.S. EPA
Enzyme Based Analytical Chemistry - Nitrate and the U.S. EPAEnzyme Based Analytical Chemistry - Nitrate and the U.S. EPA
Enzyme Based Analytical Chemistry - Nitrate and the U.S. EPA
 
PPT on spoilage (1).pptx
PPT on spoilage (1).pptxPPT on spoilage (1).pptx
PPT on spoilage (1).pptx
 
A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...
A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...
A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...
 
mdch lab poster bonita3
mdch lab poster  bonita3mdch lab poster  bonita3
mdch lab poster bonita3
 
MELA Nov2015 Presentation Deck
MELA Nov2015 Presentation DeckMELA Nov2015 Presentation Deck
MELA Nov2015 Presentation Deck
 

More from Quality Assistance s.a.

Tout ce que vous voulez savoir sur la vaccination COVID-19 (9 février 2021)
Tout ce que vous voulez savoir sur la vaccination COVID-19 (9 février 2021)Tout ce que vous voulez savoir sur la vaccination COVID-19 (9 février 2021)
Tout ce que vous voulez savoir sur la vaccination COVID-19 (9 février 2021)
Quality Assistance s.a.
 
Multiple Heartcut 2D-LC/MS: a powerful tool for biopharma analysis in a regul...
Multiple Heartcut 2D-LC/MS: a powerful tool for biopharma analysis in a regul...Multiple Heartcut 2D-LC/MS: a powerful tool for biopharma analysis in a regul...
Multiple Heartcut 2D-LC/MS: a powerful tool for biopharma analysis in a regul...
Quality Assistance s.a.
 
Structural characterisation and epitope mapping by HDX-MS (Advanced Analytica...
Structural characterisation and epitope mapping by HDX-MS (Advanced Analytica...Structural characterisation and epitope mapping by HDX-MS (Advanced Analytica...
Structural characterisation and epitope mapping by HDX-MS (Advanced Analytica...
Quality Assistance s.a.
 
Advances in analytical strategies for comparability assessment (Bioproduction...
Advances in analytical strategies for comparability assessment (Bioproduction...Advances in analytical strategies for comparability assessment (Bioproduction...
Advances in analytical strategies for comparability assessment (Bioproduction...
Quality Assistance s.a.
 
WEBINAR HDX-MS a powerful tool for biopharmaceutical characterisation
WEBINAR HDX-MS a powerful tool for biopharmaceutical characterisationWEBINAR HDX-MS a powerful tool for biopharmaceutical characterisation
WEBINAR HDX-MS a powerful tool for biopharmaceutical characterisation
Quality Assistance s.a.
 
Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiq...
Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiq...Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiq...
Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiq...
Quality Assistance s.a.
 
Nouveaux outils pour la caractérisation et l'analyse structurale des mAbs et ...
Nouveaux outils pour la caractérisation et l'analyse structurale des mAbs et ...Nouveaux outils pour la caractérisation et l'analyse structurale des mAbs et ...
Nouveaux outils pour la caractérisation et l'analyse structurale des mAbs et ...
Quality Assistance s.a.
 
Analytical methods: key considerations to efficiently bring ADCs to the market
Analytical methods: key considerations to efficiently bring ADCs to the marketAnalytical methods: key considerations to efficiently bring ADCs to the market
Analytical methods: key considerations to efficiently bring ADCs to the market
Quality Assistance s.a.
 
WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...
WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...
WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...
Quality Assistance s.a.
 
Development of quality control assays for cell-based medicinal products (ISCT...
Development of quality control assays for cell-based medicinal products (ISCT...Development of quality control assays for cell-based medicinal products (ISCT...
Development of quality control assays for cell-based medicinal products (ISCT...
Quality Assistance s.a.
 
Advances in LC/MS methodologies for the characterisation of complex glycoprot...
Advances in LC/MS methodologies for the characterisation of complex glycoprot...Advances in LC/MS methodologies for the characterisation of complex glycoprot...
Advances in LC/MS methodologies for the characterisation of complex glycoprot...
Quality Assistance s.a.
 
Advances in Mass Spectrometry for the Characterisation and Bioanalysis of ADC...
Advances in Mass Spectrometry for the Characterisation and Bioanalysis of ADC...Advances in Mass Spectrometry for the Characterisation and Bioanalysis of ADC...
Advances in Mass Spectrometry for the Characterisation and Bioanalysis of ADC...
Quality Assistance s.a.
 
Q3D - Elemental Impurities: What implications for APIs & excipients suppliers?
Q3D - Elemental Impurities: What implications for APIs & excipients suppliers?Q3D - Elemental Impurities: What implications for APIs & excipients suppliers?
Q3D - Elemental Impurities: What implications for APIs & excipients suppliers?
Quality Assistance s.a.
 
Stress testing and physico-chemical characterization of monoclonal antibodies...
Stress testing and physico-chemical characterization of monoclonal antibodies...Stress testing and physico-chemical characterization of monoclonal antibodies...
Stress testing and physico-chemical characterization of monoclonal antibodies...
Quality Assistance s.a.
 
Les Impuretés dans les Principes Actifs d'Origine Biotechnologique
Les Impuretés dans les Principes Actifs d'Origine BiotechnologiqueLes Impuretés dans les Principes Actifs d'Origine Biotechnologique
Les Impuretés dans les Principes Actifs d'Origine Biotechnologique
Quality Assistance s.a.
 

More from Quality Assistance s.a. (15)

Tout ce que vous voulez savoir sur la vaccination COVID-19 (9 février 2021)
Tout ce que vous voulez savoir sur la vaccination COVID-19 (9 février 2021)Tout ce que vous voulez savoir sur la vaccination COVID-19 (9 février 2021)
Tout ce que vous voulez savoir sur la vaccination COVID-19 (9 février 2021)
 
Multiple Heartcut 2D-LC/MS: a powerful tool for biopharma analysis in a regul...
Multiple Heartcut 2D-LC/MS: a powerful tool for biopharma analysis in a regul...Multiple Heartcut 2D-LC/MS: a powerful tool for biopharma analysis in a regul...
Multiple Heartcut 2D-LC/MS: a powerful tool for biopharma analysis in a regul...
 
Structural characterisation and epitope mapping by HDX-MS (Advanced Analytica...
Structural characterisation and epitope mapping by HDX-MS (Advanced Analytica...Structural characterisation and epitope mapping by HDX-MS (Advanced Analytica...
Structural characterisation and epitope mapping by HDX-MS (Advanced Analytica...
 
Advances in analytical strategies for comparability assessment (Bioproduction...
Advances in analytical strategies for comparability assessment (Bioproduction...Advances in analytical strategies for comparability assessment (Bioproduction...
Advances in analytical strategies for comparability assessment (Bioproduction...
 
WEBINAR HDX-MS a powerful tool for biopharmaceutical characterisation
WEBINAR HDX-MS a powerful tool for biopharmaceutical characterisationWEBINAR HDX-MS a powerful tool for biopharmaceutical characterisation
WEBINAR HDX-MS a powerful tool for biopharmaceutical characterisation
 
Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiq...
Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiq...Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiq...
Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiq...
 
Nouveaux outils pour la caractérisation et l'analyse structurale des mAbs et ...
Nouveaux outils pour la caractérisation et l'analyse structurale des mAbs et ...Nouveaux outils pour la caractérisation et l'analyse structurale des mAbs et ...
Nouveaux outils pour la caractérisation et l'analyse structurale des mAbs et ...
 
Analytical methods: key considerations to efficiently bring ADCs to the market
Analytical methods: key considerations to efficiently bring ADCs to the marketAnalytical methods: key considerations to efficiently bring ADCs to the market
Analytical methods: key considerations to efficiently bring ADCs to the market
 
WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...
WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...
WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...
 
Development of quality control assays for cell-based medicinal products (ISCT...
Development of quality control assays for cell-based medicinal products (ISCT...Development of quality control assays for cell-based medicinal products (ISCT...
Development of quality control assays for cell-based medicinal products (ISCT...
 
Advances in LC/MS methodologies for the characterisation of complex glycoprot...
Advances in LC/MS methodologies for the characterisation of complex glycoprot...Advances in LC/MS methodologies for the characterisation of complex glycoprot...
Advances in LC/MS methodologies for the characterisation of complex glycoprot...
 
Advances in Mass Spectrometry for the Characterisation and Bioanalysis of ADC...
Advances in Mass Spectrometry for the Characterisation and Bioanalysis of ADC...Advances in Mass Spectrometry for the Characterisation and Bioanalysis of ADC...
Advances in Mass Spectrometry for the Characterisation and Bioanalysis of ADC...
 
Q3D - Elemental Impurities: What implications for APIs & excipients suppliers?
Q3D - Elemental Impurities: What implications for APIs & excipients suppliers?Q3D - Elemental Impurities: What implications for APIs & excipients suppliers?
Q3D - Elemental Impurities: What implications for APIs & excipients suppliers?
 
Stress testing and physico-chemical characterization of monoclonal antibodies...
Stress testing and physico-chemical characterization of monoclonal antibodies...Stress testing and physico-chemical characterization of monoclonal antibodies...
Stress testing and physico-chemical characterization of monoclonal antibodies...
 
Les Impuretés dans les Principes Actifs d'Origine Biotechnologique
Les Impuretés dans les Principes Actifs d'Origine BiotechnologiqueLes Impuretés dans les Principes Actifs d'Origine Biotechnologique
Les Impuretés dans les Principes Actifs d'Origine Biotechnologique
 

Recently uploaded

INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
blessyjannu21
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
The Lifesciences Magazine
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
DIVYANSHU740006
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Health Catalyst
 
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPYRECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
Isha Jaiswal
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
CANSA The Cancer Association of South Africa
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
eurohealthleaders
 
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyDr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
R3 Stem Cell
 
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGYTime line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
DianaRodriguez639773
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 
The positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experienceThe positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experience
SGRT Community
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
TraumaOutpatientCent
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
Rajarambapu College of Pharmacy Kasegaon Dist Sangli
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
NX Healthcare
 
Feeding plate for a newborn with Cleft Palate.pptx
Feeding plate for a newborn with Cleft Palate.pptxFeeding plate for a newborn with Cleft Palate.pptx
Feeding plate for a newborn with Cleft Palate.pptx
SatvikaPrasad
 
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareStem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Dr. David Greene Arizona
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
nktiacc3
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
Dinesh Chauhan
 

Recently uploaded (20)

INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
 
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPYRECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
 
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyDr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
 
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGYTime line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 
The positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experienceThe positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experience
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
 
Feeding plate for a newborn with Cleft Palate.pptx
Feeding plate for a newborn with Cleft Palate.pptxFeeding plate for a newborn with Cleft Palate.pptx
Feeding plate for a newborn with Cleft Palate.pptx
 
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareStem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
 

WEBINAR: Absolute quantification of mAbs and ADCs: forget amino acid analysis and shift to the new gold standard

  • 1. 1Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Absolute quantification of mAbs and ADCs: forget amino acid analysis and shift to the new gold standard Arnaud Delobel, PhD Director, R&D
  • 2. 2Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Agenda • Presentation of Quality Assistance • Absolute quantification: why and how? • Development of an ICP/MS method for protein quantification • Method validation • How to apply the method to ADCs?
  • 3. 3Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Quality Assistance sa 100% analytical services 100% (bio)pharmaceutical industry 189 highly-qualified employees > 60% university graduates 77 worldwide R&D companies & 200 projects (2018) Product dedicated support Customised project management Compliance with EMA / FDA regulations From discovery to market place All laboratories on one site 5700 m² 9600 hours 5 clients 8 projects ADC expertise (2018) +35 years experience ~1.1 M € in machinery & equipment (2018) 22200 hours 16 clients 35 projects mAbs expertise (2018)
  • 4. 4Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 • Quantity of the active substance in a drug product is a critical quality attribute, directly linked to the efficacy and safety of the drug • A precise and accurate method is required to evaluate batch-to- batch consistency • Determination of protein concentration is a prerequisite to measure the extinction coefficient ε of a protein ▪ ε is used as part of the fine characterisation of a protein ▪ ε is used for comparability or biosimilarity studies Quantification of proteins: why?
  • 5. 5Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 • Absolute vs relative quantification: What does absolute mean ? ▪ Quantification without the reference substance ▪ No need for a well characterised standard of the protein to be quantified! • Usual « absolute » methods ▪ Colorimetric (Lowry, Bradford, BCA, …) • Usually with BSA as standard: large variability, important bias (up to 50 %) ▪ Amino Acid Analysis ▪ UV spectroscopy: requires knowledge of the molar extinction coefficient, in other words prior availability of the reference protein • Classical relative methods ▪ ELISA, LC-MS, LC-UV, … ▪ All require calibration with a standard solution of the protein to be assayed. Such a standard is not readily available in most cases Quantification of proteins: how?
  • 6. 6Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 • Complex workflow: • Low throughput method • High variability (%RSD: 5 – 10 %) • Low accuracy (90 – 110 %) Amino Acid Analysis Vacuum acidic hydrolysis Derivatisation UPLC/UV analysis
  • 7. 7Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Inductively-Coupled Plasma / Mass Spectrometry ICP/MS
  • 8. 8Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 • Metallo-proteins ▪ ICP-MS obvious for a protein containing a metallic hetero-element with a known stoechiometry. • Fe for Hemoglobin • Se for a Seleno-protein ▪ But applicable for a few proteins only ! • Common proteins ▪ Most proteins (> 95 %) contain Sulphur (Methionine and Cysteine residues) ▪ If elemental composition known: Sulphur determination = protein quantification ▪ e.g. BSA : C2932H4614N780O898S39 : 1.883 % (w/w) S Why ICP/MS for protein analysis?
  • 9. 9Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 • High ionization potential (10.4 eV) → low sensitivity • For 32S+, 34S+, 32SO+, 34SO+ : many polyatomic interferences Sulphur determination by ICP/MS: a challenge!
  • 10. 10Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Sulphur determination by ICP/MS • New instrument technology available: ICP-QQQ (Agilent 8800/8900 Triple Quadrupole) • Allows operation in MRM-like mode • Elimination of virtually all interferences • High sensitivity • LOQ governed by residual sulphur in reagents and solvents
  • 11. 11Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 • Sample preparation: digestion is needed • High sensitivity requires low contamination • Sulphur contained in the formulation must be taken into account • To increase accuracy and precision: isotope dilution with 34SO4 (IDMS) Method development Undigested sample solutions Sulphur recovery 1 ppm S as H2SO4 100 % 1 ppm S as Methionine > 95 % 1 ppm S as BSA < 90 %
  • 12. 12Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Quantification using Isotope Dilution
  • 13. 13Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Quantification using Isotope Dilution
  • 14. 14Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Quantification using Isotope Dilution
  • 15. 15Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 • Isotope ratio: Q1 & Q2 are set alternatively to 32/48 or 34/50 to measure 32S or 34S • Double IDMS ▪ Black marbles = 34SO4 solution added to samples ▪ 34SO4 spiking solution is prepared by oxidation of 34S Sulfur: its exact concentration is not accurately known. ▪ Concentration of the 34SO4 solution is determined by reverse IDMS with a certified solution of SO4 (natural Sulfur isotopic abundance), NIST traceable. ▪ Reverse isotope dilution allows also to compensate for sentivity differences observed in ICP-MS between 32S and 34S (mass discrimination) Quantification using Isotope Dilution
  • 16. 16Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Workflow of the method 34S Oxidation (HNO3 / H2O2, 30’) Standard stock solution Addition of sulphur ICP standard
  • 17. 17Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Workflow of the method 34S Mineralisation (HNO3 / H2O2, 30’) Standard stock solution Addition of sulphur ICP standard
  • 18. 18Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Workflow of the method Standard stock solution Sample solution (50 µg S in 1-5 mL) 3 kDa MWCO-filtered sample solution Mineralisation (HNO3 / H2O2 / HCl, 30’) ICP-MS/MS analysis Sulphur (32S/34S) quantification by IDMS Absolute protein quantification
  • 19. 19Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 ICP-MS parameters • RF power: 1550 W • Ar carrier gas: 0.25 L/min • Dilution gas (Ar): 0.85 L/min • O2 in reaction cell: 0.35 ml/min • First quadrupole at m/z = 32 (or 34 for 34S) • Last quadrupole at m/z = 48 (or 50 for 34SO+) Total: 1.1 L/min
  • 20. 20Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 • According to ICH Q2(R1) guideline (Validation of analytical procedures – Text and methodology) • Model compound: BSA (Bovine Serum Albumin) NIST certified solution: 67.38  1.38 g/L ( 2.0 %) • Additional compounds tested ▪ Trastuzumab solution (label concentration: 21 mg/mL) ▪ Human IgG (Immunoglobulins mixture from Ph. Eur.) ▪ USP BSA for Protein Quantitation RS (2.00 mg/mL) Method validation
  • 21. 21Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 • Linearity of the method: ▪ R = 0.99998 ▪ Precision: RSD < 0.4 % ▪ Accuracy: 101.2 – 101.3 % Method validation - Linearity BSA (SRM 927e) (mg) Sulphur (µg) Sulphur (µg/g) Average recovery (%) RSD (%) n 1.6 30 0.6 101.29 0.34 3 2.1 40 0.8 101.30 0.21 3 2.6 50 1.0 101.26 0.22 6 3.2 60 1.2 101.17 0.13 3 3.7 70 1.4 101.17 0.12 3 y = 19.02520x + 0.09521 R² = 0.99996 20 30 40 50 60 70 80 1 1.5 2 2.5 3 3.5 4 Sulfurfound,µg Sample mass (BSA dose, mg)
  • 22. 22Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Method validation - Precision (repeatability and intermediate precision) • Two different analysts carried out independently 6 determinations of the same solution of BSA and human IgG . • Samples ▪ BSA: NIST, SRM 927e: 67.38 mg/mL ▪ IgG: human immunoglobulin BRP batch 1 • Ph. Eur. Reference standard for molecular size: unknown content Sample Analyst 1 Analyst 2 Total RSD (%) Average % RSD (n = 6) Average % RSD (n = 6) n = 12 NIST BSA (mg/mL) 67.28 0.41 67.50 0.52 0.6 IgG (mg S/g) 8.39 0.13 8.33 0.19 0.7
  • 23. 23Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 • Evaluation of matrix effect ▪ Same amount of BSA spiked with different formulation ingredients Method validation – Matrix effect Matrix Mean recovery (%) % RSD (n = 3) 0.9 % NaCl 100.27 0.05 PBS 100.24 0.36 10 % Sucrose 100.16 0.61 0.1 % PS-80 100.26 0.57 15 mg/mL Glycine 99.61 0.37 15 mg/mL Histidine 100.76 0.23 Worst case 100.33 0.21
  • 24. 24Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 • Quantification in the presence of non-proteinaceous sulphur: ▪ Source of non-protein sulphur: Sulphate ▪ A BSA solution is spiked with SO4 ( 5 % of BSA Sulphur) ▪ Part of this solution is filtered through 3 kDa • Corrected BSA recovery in spiked solution: 99.6 % Method validation – Matrix effect Sample Sulphur (µg/g) A: unspiked BSA solution 36.50 B: spiked BSA solution 38.81 C: filtered solution 2.44 B-C 36.37
  • 25. 25Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Method validation – Matrix effect • Quantification in the presence of non-proteinaceous sulphur: ▪ Non-protein sulphur: Methionine ▪ Methionine was added to BSA and IgG solution ▪ Solutions were filtered and Methionine recovery measured in filtrate 25 BSA sol IgG sol Methionine added (mM) 2.05 2.05 Methionine in filtrate (mM) 2.03 2.04 % recovery 99.1 99.5
  • 26. 26Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Method validation - Stability of solutions • Stability of standard, sample and blank solutions were studied after digestion and dilution • Storage in metal-free polypropylene tubes • 34S/32S ratios measured on different days: no change > 1 % in 7 days → All solutions are stable for at least 7 days
  • 27. 27Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Method validation – Impact of sample dilution • What if we have a sample with low protein concentration? → Need for a large volume of sample to get 50 µg of S → Dilution of acids used for digestion → Will the digestion be complete? • Test: ▪ Constant amount of BSA solution (40 mg) and of 34SO4 ▪ Constant volumes of digestion reagents (2 mL HNO3, 0.5 mL HCl, 1 mL H2O2) ▪ Variable volumes of water added before digestion (1 to 5 mL)
  • 28. 28Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Method validation – Impact of sample dilution BSA solution (mg) H2O (mL) Mean recovery (%) RSD (%) n 40 0.9 100.51 0.32 3 40 1.4 100.92 0.34 3 40 2.0 100.59 0.18 3 40 2.5 100.64 0.07 3 40 3 100.32 0.14 3 40 4 100.89 0.15 3 40 5 100.77 0.18 3
  • 29. 29Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Study on Trastuzumab and USP BSA Trastuzumab solution • Expected concentration: 21 mg/mL • Unknown formulation • Non proteinaceous Sulphur: 1.7 ppb ( 0.2 % of Trastuzumab Sulphur) • Found: 20.53 mg/g (RSD = 0.02 %, n = 3) • Recovery: 97.8 % (vs. the nominal concentration) • Result should be corrected for density (unknown) BSA for Protein Quantitation (USP Reference Standard) • Label concentration: 2.00 mg/mL (unknown accuracy, determined on basis of UV 280nm absorption) • Found: 1.96 mg/mL (RSD = 0.4 %, n=3) • Recovery: 98.0 % (vs. label concentration)
  • 30. 30Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Conclusions • The method characteristics are: ▪ Good sensitivity: 1 or 2 mg of protein in 5 mL is enough ▪ High reproducibility: RSD < 1 % ▪ Great accuracy: < 2 % bias ▪ Insensitivity to matrix effect ▪ Same method for any protein or peptide ▪ Uses only very common reagents and standards ▪ Fast: results obtained within half a day of lab work in routine use • It is suitable for: ▪ Assay of a single protein or mAb in solution ▪ Assay of a protein adsorbed on an adjuvant (vaccines) ▪ Accurate determination of a protein or peptide standard solution concentration ▪ Determination of the molar extinction coefficient • Excellent orthogonal method to colorimetry, AAA, theoretical molar extinction coefficient
  • 31. 31Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Comparison of protein quantification methods not requiring the reference protein Colorimetry Extinct. coeff. (calculated) Amino Acids Analysis Sulfur by ICP-MS Single protein Yes Yes Yes Yes Need for a standard protein Yes (BSA) No No (Amino Acids) No (Sulfate sol.) Bias Significant Can be significant 5 - 10 % < 2 % Precision (% RSD) > 5 % N/A > 5 % < 1 % Interferences Yes Yes (ex: ADC) No No
  • 32. 32Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 How to apply the method to ADCs? • If the drug/linker contains no sulphur: easy! • If the drug/linker contains sulphur: Determination of DAR by LC/MS Calculation of mean number of sulphur atoms per ADC ICP-MS/MS analysis and determination of ADC concentration
  • 33. 33Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Take-Home Messages AAA is no longer the reference method for absolute quantification of proteins You no longer have to accept > 10% uncertainty in your extinction coefficient determination Our ICP/MS method was validated and showed excellent precision and accuracy (RSD < 1%, bias < 2%) The method can be applied on a wide range of formulations without further optimisation The method can be run in a full GMP environment
  • 34. 34Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 Acknowledgements • Juliusz Bianga • Damien Mouvet • Philippe De Raeve
  • 35. 35Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019 arnaud.delobel@quality-assistance.be +32 71 53 47 81 www.quality-assistance.com Technoparc de Thudinie, 2 B-6536 Donstiennes (Belgium) Thank you for your attention Any question?